Q3 2018 13F Holders as of 30 Sep 2018
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
22,278,088
-
Total 13F shares
-
7,500,122
-
Share change
-
+316,619
-
Total reported value
-
$423,927,111
-
Put/Call ratio
-
82%
-
Price per share
-
$56.54
-
Number of holders
-
164
-
Value change
-
+$15,362,009
-
Number of buys
-
82
-
Number of sells
-
80
Institutional Holders of ANI PHARMACEUTICALS INC - Common Stock, par value $0.0001 per share (ANIP) as of Q3 2018
As of 30 Sep 2018,
ANI PHARMACEUTICALS INC - Common Stock, par value $0.0001 per share (ANIP) was held by
164 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
7,500,122 shares.
The largest 10 holders included
BlackRock Inc., Vanguard Group Inc, MANGROVE PARTNERS, DIMENSIONAL FUND ADVISORS LP, LSV ASSET MANAGEMENT, NOMURA HOLDINGS INC, STATE STREET CORP, FIRST MANHATTAN CO, RENAISSANCE TECHNOLOGIES LLC, and Invesco Ltd..
This page lists
164
institutional shareholders reporting positions in this security
for the Q3 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.